Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
66.3M
-
Shares change
-
+1.87M
-
Total reported value, excl. options
-
$935M
-
Value change
-
+$30.5M
-
Put/Call ratio
-
0.93
-
Number of buys
-
65
-
Number of sells
-
-85
-
Price
-
$14.10
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2021
198 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q4 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.3M shares
of 101M outstanding shares and own 65.79% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (13M shares), VANGUARD GROUP INC (9.04M shares), BlackRock Inc. (6.65M shares), FIRST TRUST ADVISORS LP (5.32M shares), STATE STREET CORP (4.51M shares), Point72 Asset Management, L.P. (3.73M shares), GEODE CAPITAL MANAGEMENT, LLC (1.63M shares), Soleus Capital Management, L.P. (1.55M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.39M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.31M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.